According to the public registry, the trial was completed, and the results suggest a favorable safety profile with no significant adverse events reported (ClinicalTrials.gov Identifier: NCT03416053)
Beta-Alanine and Creatine: Creatine and beta-alanine are highly complementary
Hattori J, Yamakage M, Seki S, Okazaki K, Namiki A
Since admission, she had been on IV flucloxacillin 2 g four times daily, acetaminophen 1g four times daily and had received 5 L normal saline with the justification of poor intake This clinical deterioration occurred on day 10 of her admission
The pharmacokinetics of LY3437943 (retatrutide) support once-weekly administration due to an elimination half-life of approximately 6 days. Jastreboff AM et al., Nature Medicine, 2023 This extended half-life is made possible by attaching a fatty acid chain to the peptide, allowing it to bind to albumin a common protein in your blood that acts like a slow-release carrier
A 4 mg dose is 50 units (0.50 mL)